Contact us
Young GI
Patients
Industry
Press
My Connect
Create myUEG account
About
To landing page
Who we are
Boards, Committees & Groups
Governance
Headquarters Management
History
What we do
Strategic Drivers
Year in Review
Our Members
Specialist Member Societies
National Member Societies
myUEG Community
myUEG Associates
My Connect
Women in GI
Young GIs
Researchers
Event Calendar
Week
To landing page
Programme
Postgraduate Teaching
Industry Programme
List of Supporters & Exhibitors
CME Accreditation
UEG Week on-demand
Future UEG Weeks
Education
To landing page
Online Education
Online Courses
Webinars
Career Development
Face-to-face Education
Summer School
Masterclass
Clinical Visiting Fellowships
Education Resources
Mistakes in...
UEG Talks Podcast
Image Hub
CME in Europe
Event Endorsement
Supporters
Research
To landing page
Support
Horizon Europe Support
Start-up Grant
Research Prize
Research Fellowship
Research Webinars
Research Projects
HoloSurge
Position Papers
White Book 2
Main Results
Full Reports
Materials and Presentations
Quality of Care
To landing page
Search Guidelines
Standards & Guidelines Repository
Non-English Guidelines
GI Guidelines App
Develop & Implement
How to develop guidelines
Guideline Endorsement
Guideline Webinars
Projects
Quality of Care Initiatives
Quality Standards
Public Affairs
To landing page
Advocacy
Core Positions
Stakeholder Collaboration
White Book 2
Position Papers
MEP Digestive Health Group
Our Supporters
#EUNewsline →
EU Elections 2024
Publications
To landing page
Publications
Congress Publications
Research Publications
Public Affairs Publications
Education Publications
UEG Publications
UEG Journal →
UEG Journal Podcast
White Book 2
Opportunities
To landing page
Congress Opportunities
Top Abstract Prizes
National Scholar Award
Travel Grants
International Scholarship Awards
Research Funding
Research Prize
Research Fellowship
Horizon Europe Support
Start-up Grant
Activities Funding
Recognition of Achievements
Lifetime Achievement Award
Journal Best Paper Award
Activities Endorsement
Professional Advancement
Rising Star Awards
Clinical Visiting Fellowships
Open Positions
Talent Pool
Library
To landing page
Congress Resources
UEG Week on-demand
Abstracts
Posters
Guideline Resources
Education Resources
Image Hub
Webinars
Mistakes in... articles
Contact us
Young GI
Patients
Industry
Press
Author
Charlie W. Lees
JAK Inhibition in Practice: Continuing the Story Thread (Pfizer INC)
Charlie W. Lees
et al.
Webinar: COVID-19 & Digestive Health #6 | IBD: Treatment, Service and Research (Update)
Charlie W. Lees
et al.
Webinar: COVID-19 & Digestive Health #3 | IBD: Treatment, Service and Research
Charlie W. Lees
et al.
Can Flexible Treatment Administration Impact Outcomes in Inflammatory Bowel Disease? (Takeda Pharmaceuticals International AG)
Charlie W. Lees
et al.
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Charlie W. Lees
et al.
It takes two to tango in UC: let’s get in sync with our patients (Pfizer Inc.) (Complete Session)
Charlie W. Lees
et al.
INFLAMMATORY BOWEL DISEASE: A PHENOME-WIDE PRE- AND POST-DIAGNOSTIC ASSOCIATION STUDY
Charlie W. Lees
et al.
A SYSTEMATIC REVIEW AND META-ANALYSIS OF THE EFFICACY AND SAFETY OF INFLIXIMAB AND VEDOLIZUMAB IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
Charlie W. Lees
et al.
LATENT CROHN’S DISEASE SUBGROUPS ARE IDENTIFIED BY FAECAL CALPROTECTIN PROFILES: A RETROSPECTIVE ANALYSIS OF THE LOTHIAN CROHN’S DISEASE INCEPTION COHORT
Charlie W. Lees
et al.
THE OUTCOMES OF PATIENTS TREATED WITH 2ND AND 3RD LINE BIOLOGICAL IN PERIANAL CROHN’S DISEASE (PCD) – A MULTICENTRE PROPENSITY SCORE MATCHED STUDY
Charlie W. Lees
et al.
MULTIPLE INFLIXIMAB BIOSIMILAR SWITCHES APPEAR TO BE SAFE AND EFFECTIVE IN A REAL-WORLD IBD COHORT
Charlie W. Lees
et al.
LONG-TERM VEDOLIZUMAB PERSISTENCE IN ULCERATIVE COLITIS: THE EDINBURGH IBD UNIT EXPERIENCE 2014-2022
Charlie W. Lees
et al.
BOTH SINGLE AND MULTIPLE SWITCHING BETWEEN INFLIXIMAB BIOSIMILARS CAN BE SAFE AND EFFECTIVE IN IBD: REAL WORLD OUTCOMES FROM THE EDINBURGH IBD UNIT
Charlie W. Lees
et al.
FACTORS INDEPENDENTLY ASSOCIATED WITH FATIGUE IN IBD: RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY
Charlie W. Lees
et al.
PATIENT PERCEPTIONS ABOUT CAUSES OF FLARE IN INFLAMMATORY BOWEL DISEASE (IBD): RESULTS FROM THE BASELINE DATASET OF THE PREDICCT STUDY
Charlie W. Lees
et al.
PREDICCT COHORT BASELINE HABITUAL NUTRIENT INTAKE BY IBD PATIENTS
Charlie W. Lees
et al.
LONG-TERM OUTCOMES FOLLOWING A SWITCH FROM ORIGINATOR ADALIMUMAB TO THE BIOSIMILAR SB5 (IMRALDI) IN IBD
Charlie W. Lees
et al.
COVID-19 VACCINE-INDUCED ANTIBODY AND T CELL RESPONSES IN IMMUNOSUPPRESSED PATIENTS WITH INFLAMMATORY BOWEL DISEASE AFTER THE THIRD VACCINE DOSE
Charlie W. Lees
et al.
Item 1 - 18 / 18
1
Chat with us
, powered by
LiveChat